enramycin: isolated from cultures of Streptomyces fungicidicus [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 56842192 |
| MeSH ID | M0129828 |
| Synonym |
|---|
| enduracidin |
| enradin |
| enramycin |
| 11115-82-5 |
| enramicina [inn-spanish] |
| enramycinum [inn-latin] |
| enramycin [inn] |
| antibiotic obtained from cultures of streptomyces fungicidicus b 5477, or the same substance produced by any other means |
| 4gp7clg9eg , |
| enramicina |
| unii-4gp7clg9eg |
| enramycinum |
| enduracidin hydrochloride |
| 12772-37-1 |
| pubchem_56842192 |
| DTXSID10718649 |
| Q17119098 |
Enramycin is a polypeptide antibiotic and new, safe animal feed additive.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Enramycin is a polypeptide antibiotic and new, safe animal feed additive. " | ( [Purification of enramycin by macroporous resin adsorption and reversed phase chromatography purification]. Guodong, Z; Jiaxin, W; Jihong, H; Meixian, Z; Peng, Q; Ping, L; Yongdong, H, 2014) | 2.18 |
Enramycin treatment promoted the expression of peptide (bcrA), glycopeptide (vanRI), and lincosamide (lsaE) resistance genes. Treatment with enramYcin was associated with decreased richness and with lower relative abundance of unclassified Firmicutes, Clostridium XI, and Peptostreptococcaceae.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Enramycin treatment promoted the expression of peptide (bcrA), glycopeptide (vanRI), and lincosamide (lsaE) resistance genes but inhibited the expression of aminocoumarin (parY) and pleuromutilin (TaeA) resistance genes." | ( Bacillus licheniformis-fermented products and enramycin differentially modulate microbiota and antibiotic resistome in the cecal digesta of broilers. Chen, YC; Yu, YH, 2022) | 1.7 |
| "Treatment with enramycin was associated with decreased richness and with lower relative abundance of unclassified Firmicutes, Clostridium XI, unclassified Peptostreptococcaceae (all P<0.001) and greater abundance of Clostridium XIVb (P = 0.004) and Anaerosporobacter spp." | ( Different antibiotic growth promoters induce specific changes in the cecal microbiota membership of broiler chicken. Alfieri, AA; Bessegatto, JA; Costa, MC; Filho, JA; Oba, A; Weese, JS, 2017) | 0.79 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (40.36) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 2 (20.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||